Cargando…
DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients
BACKGROUND: Loss of A, B and H antigens from the red blood cells of patients with myeloid malignancies is a frequent occurrence. Previously, we have reported alterations in ABH antigens on the red blood cells of 55% of patients with myeloid malignancies. METHODOLOGY/PRINCIPAL FINDINGS: To determine...
Autores principales: | Bianco-Miotto, Tina, Hussey, Damian J., Day, Tanya K., O'Keefe, Denise S., Dobrovic, Alexander |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2650780/ https://www.ncbi.nlm.nih.gov/pubmed/19274076 http://dx.doi.org/10.1371/journal.pone.0004788 |
Ejemplares similares
-
Allelic distribution of ABO gene in Chinese centenarians
por: Zhu, Ying, et al.
Publicado: (2020) -
ABO-incompatible granulocyte transfusion: Is ABO subgroup a barrier?
por: Agrawal, Soma, et al.
Publicado: (2022) -
Significantly lower antigenicity of incobotulinumtoxin than abo- or onabotulinumtoxin
por: Hefter, Harald, et al.
Publicado: (2022) -
Allele Frequency of ABO Blood Group Antigen and the Risk of Esophageal Cancer
por: Kumar, Narender, et al.
Publicado: (2014) -
Association of ABO Blood Group Phenotype and Allele Frequency with Chikungunya Fever
por: Rujirojindakul, Pairaya, et al.
Publicado: (2015)